AB Sciex Taking over Management of Beckman Coulter's Capillary Electrophoresis Unit | GenomeWeb

NEW YORK (GenomeWeb News) – AB Sciex today announced that it is combining its Eksigent chromatography business with the capillary electrophoresis unit of its fellow Danaher stablemate Beckman Coulter.

The move, which the company said will include the transfer of personnel as well as technology, is designed to bolster AB Sciex's separations business and could aid in advancing analysis of target drugs, drug metabolites, organic acids, amino acids, low molecular weight amines, peptides, nucleic acids, and nucleosides.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: tool to discover copy number variants, single-nucleus RNA sequencing study of myoblasts, and more.

A study of Tasmanian devil genomes suggests they are evolving resistance to devil facial tumor disease.

Theranos has withdrawn its request for emergency clearance of a Zika virus blood test, according to the Wall Street Journal.

An assistant professor who was fired from Mount Sinai School of Medicine has allegedly shot the school's dean, the New York Times reports.